A Phase Ib/II Clinical Study of Camrelizumab and Apatinib Plus GP in the Treatment of Advanced Biliary Tract Cancer

NCT05742750 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Biliary Tract Cancer
Metastatic Biliary Tract Cancer

Interventions

DRUG: Camrelizumab and Apatinib Plus GP

Sponsor

Sun Yat-sen University

Collaborators

[object Object]